[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.129.152. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
June 23/30, 1999

Prostate Detection Possibility

Author Affiliations
 

Not Available

Not Available

JAMA. 1999;281(24):2274-2275. doi:10.1001/jama.281.24.2274-JMN0623-3-1

Dallas—As some clinicians consider lowering the prostate-specific antigen (PSA)–alerting threshold for possible adenocarcinoma to 2.5 ng/mL, researchers are exploring a role for an enzymatic "cousin" of PSA in this diagnostic process.

This substance is human kallikrein 2 (hK2) enzyme, recently purified by Donald J. Tindall, PhD, at the Mayo Clinic Foundation in Rochester, Minn. The enzyme has an 80% structural similarity to PSA, which technically is hK3. Like PSA, hK2 is secreted by prostate epithelial cells, and normally converts the inactive form of PSA (pro-PSA) into the enzymatically active form (PSA, the enzyme). (The other known human kallikrein enzyme, hK1, is not produced by the prostate.)

First Page Preview View Large
First page PDF preview
First page PDF preview
×